%0 Journal Article
%T Advances in dyslipidemia management for prevention of atherosclerosis: PCSK9 monoclonal antibody therapy and beyond
%A Nathan D. Wong
%A Paul D. Rosenblit
%A Robert S. Greenfield
%J Archive of "Cardiovascular Diagnosis and Therapy".
%D 2017
%R 10.21037/cdt.2017.03.02
%K Proprotein convertase subtilisin kexin type 9 (PCSK9)
%K dyslipidemia
%K LDL-cholesterol
%K atherosclerosis
%K cardiovascular disease
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418210/